Ixico Plc (IXI) New Ord GBP0.01

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Ixico upbeat on breakthrough with AI imaging platform
12 February 2025 14:51
(Sharecast News) - Ixico announced further validation of its AI-driven imaging platform IXIQ.Ai in Huntington's disease (HD) research on Wednesday, through its collaboration with the Huntington's...
-
Ixico secures new contract with US-based client
10 December 2024 10:45
(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.
-
Ixico raises expectations on new contract wins
14 August 2024 12:22
(Sharecast News) - Medical imaging advanced analytics technology company Ixico said in a trading update on Wednesday that it expected its financial performance to surpass market expectations, driven by new...
-
Ixico reports progress in Huntington's disease imaging consortium
29 July 2024 12:02
(Sharecast News) - Medical imaging analytics specialist Ixico reported significant progress in its Huntington's disease imaging harmonisation (HD-IH) consortium on Monday.
-
Ixico wins £1m research contract
19 June 2024 10:35
(Sharecast News) - Precision analytics company Ixico announced a new contract valued at over £1m on Wednesday.
-
Ixico inks supply agreement with LMI
15 April 2024 09:31
(Sharecast News) - Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical...
-
Ixico warns on 2024 revenue amid contract delays
13 March 2024 12:25
(Sharecast News) - Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked...
-
Ixico CEO to step down by end of year
12 January 2024 15:51
(Sharecast News) - Medical imaging analytics company Ixico announced on Friday that its chief executive officer Giulio Cerroni planned to retire from his position, and as a director, by the end of 2024.
-
Ixico full-year earnings could slightly exceed forecasts
29 September 2023 13:08
(Sharecast News) - Advanced medical imaging analytics specialist Ixico said in an update on Friday that its earnings for the financial year would either meet or exceed market predictions, even though it...
-
Ixico awarded new £2m, four-year contract
14 June 2023 14:17
(Sharecast News) - Medical imaging and analytics specialist Ixico has been awarded a new contract by an existing client, it announced on Wednesday, to provide imaging services for the extension study of...
-
Ixico set to report first-half loss as legacy issues unwind
10 May 2023 12:36
(Sharecast News) - Medical imaging analytics specialist Ixico reported first-half revenue of £3.2m in a trading update on Wednesday, down from £3.9m in the first six months of the 2022 financial year.
-
Ixico wins £700,000 contract with biotech company
10 March 2023 08:43
(Sharecast News) - Clinical research firm Ixico has won a contract to provide MRI imaging services for patient selection and efficacy analysis in patients with a rare form of dementia.
Company announcements Announcements
-
Contract Win
27 February 2025 07:00
Ixico
-
Further Validation of IXICO’s AI Imaging Platform
12 February 2025 07:00
Ixico
-
Issue of share options and PDMR dealing
7 February 2025 15:00
Ixico
-
Result of AGM
24 January 2025 14:16
Ixico
-
Commercial agreement with PETNET Solutions Inc
16 December 2024 07:00
Ixico
-
Contract Win
10 December 2024 07:00
Ixico
-
Share Option Award & PDMR Dealings
4 December 2024 11:35
Ixico
-
Financial Results for year ended 30 September 2024
4 December 2024 07:00
Ixico
-
Notice of Results and Investor Presentation
25 November 2024 07:00
Ixico
-
Share Option Awards & PDMR Dealing
31 October 2024 07:00
Ixico
-
Holding(s) in Company
30 October 2024 16:50
Ixico
-
Holding(s) in Company
29 October 2024 10:58
Ixico
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.